Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2019-04-12 Capital/Financing Update
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
FORM S-3/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-3/A registration statement amendment filed with the SEC, specifically an amendment to a registration statement under the Securities Act of 1933. It details a rights offering for equity capital, describing the securities to be registered, offering terms, subscription rights, and related information. This type of filing is a capital raising document related to financing activities, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement for securities issuance. Therefore, it fits the Capital/Financing Update (CAP) category.
2019-04-12 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission regarding a Registration Statement on Form S-3/A. It discusses the withdrawal of a request to accelerate the effective date of the registration statement. The content is correspondence related to regulatory filings and does not contain financial data, report content, or detailed financial analysis. The document length is short (961 characters), and it is a formal communication about a regulatory filing process rather than the filing itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such correspondence and regulatory communications.
2019-04-10 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3/A. It is a correspondence related to a securities registration process, not a financial report or announcement of financial results. The document is short (1359 characters) and is a formal regulatory communication. It does not contain financial data, audit information, or report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2019-04-10 English
PRIMARY DOCUMENT
Director's Dealing
2019-04-09 English
FORM S-3/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-3/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It details a securities offering, specifically a rights offering to raise equity capital, including subscription rights, warrants, and common stock. The document includes information about the offering terms, use of proceeds, risk factors, and other related disclosures. This type of filing is related to capital raising activities and financing updates rather than financial results, management changes, or regulatory certifications. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual filing, not just an announcement or a brief summary.
2019-04-08 English
PRIMARY DOCUMENT
Director's Dealing
2019-04-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.